Skip to content
TrialScanner

NCT05153434

A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome

Phase 2CompletedAARDLead

Registry record

Lead sponsor
Aardvark Therapeutics, Inc.
Conditions
Prader-Willi Syndrome
Primary completion
Sep 24, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05153434 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05153434: A Study of Oral ARD-101 in... | TrialScanner